A corresponding immunohistochemical analysis of MT3 expression in a small archival set of patient samples of human breast cancers showed that all breast cancers stained positive for the MT3 protein and that the level of expression was associated with cancers having a poor prognosis. Here, MT3 is linked to breast carcinoma.